Pharmaceuticals, Biotechnology and Life Sciences
Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab) Four-Week Dosing Schedule for the Adjuvant Treatment of Adult…
MAINZ, Germany–(BUSINESS WIRE)–BioNTech SE (“BioNTech”), a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other…
DUBLIN–(BUSINESS WIRE)–The “US Fecal Microbiome Transplant Market Outlook 2025” report has been added to ResearchAndMarkets.com’s offering. “US Fecal Microbiome Transplant…
DUBLIN–(BUSINESS WIRE)–The “Central Nervous System Drugs Global Market Forecast To 2022” report has been added to ResearchAndMarkets.com’s offering. Where is…
GW Pharmaceuticals paved a way to launch Epidyolex in Europe, for use as adjunctive therapy of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients 2 years of age and older.
Faron Pharma posted operating loss of €6.3 million for the six months ended 30 June 2019, cutting it from the same period last year, of €14.0 million.
Roche will present a number of studies across its comprehensive oncology portfolio, covering a broad range of cancers including bladder, lung and breast will be presented at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain.
Infiniti Research has recently completed its latest competitive intelligence engagement for a pharmaceutical logistics company, helping the client to enhance their accuracy in demand forecasting by 15%.
MIAMI & JERSEY CITY, N.J.–(BUSINESS WIRE)–Noven Pharmaceuticals, Inc. today announced its decision to appoint Dr. Naruhito Higo as Chief Executive…